An Overview of the Practice-Changing Information From the 2013 ASCO Meeting
Sandra Swain, MD, from the Washington Cancer Institute at MedStar Washington Hospital Center, on the practice-changing information from the 2013 ASCO Meeting.
Sandra Swain, MD, medical director of the Washington Cancer Institute at MedStar Washington Hospital Center, gives an overview of the practice-changing information from the 2013 American Society of Clinical Oncology (ASCO) Meeting.
Swain mentions a trial in stage I seminoma, which showed that radiation or chemotherapy is not necessary after surgery. In a breast cancer trial, there is not a need for an axillary nodal dissection after a positive sentinel node biopsy. Radiation is as effective in this setting as axillary dissection.
Swain highlights another study that found that fitness among middle-aged men can decrease cancer incidence and improve survival.
<<<
Brain Cancer Awareness Month: Challenges and Innovations in Treatment
May 13th 2024In an interview with Targeted Oncology for Brain Cancer Awareness Month, Theodore Schwartz, MD, discussed the challenges of targeting brain tumors, emerging therapies, and strategies to overcome the blood-brain barrier.
Read More
SELECT Trial Establishes Lenvatinib’s Role in RAI-Refractory DTC
May 2nd 2024In an interview with Targeted Oncology, Lori J. Wirth, MD, delved into how the data from SELECT signals lenvatinib effectiveness as a frontline therapy for patients with RAI-refractory differentiated thyroid cancer.
Read More
